Simultaneous Pseudoprogression and an Immune-related Adverse Event of Pulmonary Pleomorphic Carcinoma after Combined Therapy with Cytotoxic Anticancer Agents and Immune Checkpoint Inhibitor-Reference-Cited by-同舟云学术

Simultaneous Pseudoprogression and an Immune-related Adverse Event of Pulmonary Pleomorphic Carcinoma after Combined Therapy with Cytotoxic Anticancer Agents and Immune Checkpoint Inhibitor

Published:2022-11-01 Issue:21 Volume:61 Page:3259-3264
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Murao Koutaro¹,Mori Yuki²,Takahashi Yukino³,Ishikawa Tatsuru²,Asai Yuichiro²,Kobayashi Tomofumi²,Ikeda Kimiyuki²,Kuronuma Koji²,Magara Kazufumi⁴,Fujita Hiromi⁵,Hirohashi Yoshihiko⁴,Takasawa Akira⁴,Chiba Hirofumi²

Affiliation:

1. Department of Respiratory Medicine, Sapporo Kosei General Hospital, Japan

2. Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Japan

3. Respiratory Medicine, Hakodate Municipal Hospital, Japan

4. Department of Pathology, Sapporo Medical University School of Medicine, Japan

5. Department of Surgical Pathology, Sapporo Medical University School of Medicine, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/61/21/61_8916-21/_pdf